Specialities and Expertise:Biotechnology, Individualized Cancer Medicine, Patient-Specific Immunotherapy, mRNA Therapeutics, Cell Therapy, Antibody Therapeutics, Small Molecule Immunomodulators, Tailored Therapeutics, Immunotherapy, Oncology, CAR T, TCR, Bispecific Antibodies, Rare Diseases, Infectious Diseases, Coronavirus, Vaccines and Therapeutics.
Size and Minority Status
- Products and services 2
- Сommodity codes
BioNTech Therapeutic Development includes RNA Pharmaceuticals, Cell & Gene Therapies, Protein Therapeutics, and Small Molecules.
BioNTech has started an mRNA-based influenza vaccine BNT162 program to combat Coronavirus disease COVID-19.
Locations Served 2
Public Spend Forum compiles the information shown in GovShop's supplier profiles based on multiple sources and relies on GovShop's supplier and buyer user community to help validate the information. We recommend conducting further due diligence and research to validate the information if accuracy is critical.